Align Technology (ALGN) said on Tuesday morning its board has authorized the repurchase of up to $1 billion of the medical device company's common shares over the next three years.
The dental technology company completed its most recent stock buyback program in May 2025, or roughly 28 months after the prior $1 billion buyback program began in January 2023.
Price: 176.12, Change: -1.49, Percent Change: -0.84